Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in Pharma

Over View Of API In 2018 Across Globe With Substantive Mention

For the overall industry, Increasing healthcare needs / awareness have resulted in healthcare expenses to grow

Read More

Sun Pharma: Global Is Local

‘We are meticulously nurturing the specialty business and have built a portfolio of about 10 specialty products’

Read More

Sun Pharma Tumbles After Report Of Probe

Markets regulator Securities and Exchange Board of India (SEBI) is likely to reopen an insider trading case against Sun, media sources reported

Read More

Lupin Second-Quarter Profit Dives As U.S. Sales, Higher Expenses Weigh

Lupin's sales in North America, which accounts for nearly a third of total sales, dropped 8.3 percent to 12.49 billion rupees ($169.06 million). Income from operations rose marginally to 38.91 billion rupees

Read More

Supreme Court Allows Sale Of Saridon, 3 Other Drugs

A two judge bench in Supreme Court has allowed the sale of Saridon and three other banned fixed dose combinations (FDCs) amongst 328 drugs banned by the Health Ministry in its Sept 7 notification

Read More

India Bans 328 Combination Drugs In Setback For Pharma Companies

Combination drugs are used to improve patients' compliance, as it is easier to get patients to take one drug rather than several

Read More

HC Suspends Till Oct Centre's Ban on Oxytocin drug production & Sale by Pvt Firms, Next Hearing on Sep 12

HC's interim ban comes on pleas by private firms seeking to set aside the Government's ban on Oxytocin drug production and sale which was to come into effect from tomorrow.

Read More

Fortis Healthcare Quarterly Loss Widens On Impairment Charges

Fortis has become the target of a bidding war by suitors seeking to get a share of a boom in India's private healthcare market

Read More

Dilip Shanghvi: Creating Milestones All The Way

Finding new growth areas and profitable markets is an ongoing quest for Sun Pharma’s Dilip Shanghvi

Read More

Dr Reddy's Fourth-quarter Profit Falls 19% On US Headwinds

Revenue from the generics business in North America, its biggest market, dropped 6 percent to Rs 14.49 billion due to price erosions and increased competition

Read More

Future Of Drug Distribution

Every delay & shortage is an opportunity for falsified or substandard products to infiltrate the market or for life-saving drugs being sold at premium prices

Read More

Pharma firms don't need NOC for exporting drugs, medical devices

The CDSCO said tthat NOC for licensed manufacturers will be waived if "shipping bills" submitted by the manufacturer include a copy of its "valid licence".

Read More

Pharma: Shrinking Fortunes

Billionaire drug makers in India are experiencing a drop in revenue, largely due to tough market conditions in the US

Read More

Genomics: Cracking The Code

Why only a handful of new-gen startups are venturing into the genomics research landscape in India

Read More

Pfizer Expects Broad Interest For Consumer Health Business

Pfizer Inc, the largest U.S. drugmaker, expects no shortage of suitors for its consumer health business and said it would decide whether to sell, spin off or retain the unit next year.

Read More